3 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 3 |
Follow HBV: new trials by email Literature Review of HBV trials Research Report on HBV
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic Treatment Naive Subjects Infected With Hepatitis B Virus Inarigivir soproxil, Tenofovir alafenamide fumarate (TAF) - Hepatitis B, HBV | Phase 2 | Terminated | F-star Therapeutics, Inc. | 5 | 2019-10-10 | 2020-07-21 |
| Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic, Hepatitis B e Antigen-negative Subjects Infected With HBV Virus and Receiving or Stopping Treatment With a NUC Inhibitor Inarigivir soproxil, Nucleoside/nucleotide (NUC) analogue inhibitors - Hepatitis B, HBV | Phase 2 | Terminated | F-star Therapeutics, Inc. | 64 | 2019-06-18 | 2020-07-22 |
| Evaluating the Effects of Inarigivir on Immune Response and Viral Markers in Chronic Hepatitis B Patients inarigivir soproxil - HBV, Hepatitis B | Phase 2 | Terminated | F-star Therapeutics, Inc. | 8 | 2019-04-11 | 2020-04-29 |
Hepatitis B (3) · Hepatitis B, Chronic (3)
Blood-Borne Infections (3) · Chronic Disease (3) · Communicable Diseases (3) · DNA Virus Infections (3) · Digestive System Diseases (3) · Disease Attributes (3) · Hepadnaviridae Infections (3) · Hepatitis (3) · Hepatitis, Chronic (3) · Hepatitis, Viral, Human (3) · Infections (3) · Liver Diseases (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Virus Diseases (3)
Nucleobindins (1) · Nucleosides (1) · Nucleotides (1) · tenofovir alafenamide (1)
Canada (1) · Hong Kong (1) · Singapore (1) · United Kingdom (1)
Don Mitchell (2) · Prof. Lim Seng Gee (1)